首页> 外国专利> Markers for Blood-Based Diagnosis of Blindness-Related Major Eye Disease and Method for Diagnosis Using the Same

Markers for Blood-Based Diagnosis of Blindness-Related Major Eye Disease and Method for Diagnosis Using the Same

机译:与失明有关的主要眼病的血基诊断标志物和使用该标志物的诊断方法

摘要

The present invention relates to a blood marker for diagnosing major eye diseases causing blindness and a diagnostic method using the same, and more particularly, to age related macular degeneration (AMD), diabetic retinopathy, cataract, and It relates to a marker for diagnosing one or more blindness-causing eye diseases selected from the group consisting of glaucoma, and a composition, kit, and a method for diagnosing blindness-causing eye diseases using the same. The method for diagnosing blindness-causing eye disease of the present invention, a diagnostic composition, a diagnostic kit, or a method for providing information necessary for diagnosis is a new immunological diagnostic tool using plasma of a patient, and has excellent sensitivity and plasma without using a biopsy. In addition to being able to easily analyze the target, it was confirmed that high diagnostic ability was shown by combining the quantitative value of the protein and basic clinical information of the diagnostic marker, and thus it can be usefully used for diagnosis of blindness-causing eye diseases.
机译:诊断导致失明的主要眼部疾病的血液标记物及其诊断方法技术领域本发明涉及用于诊断引起失明的主要眼部疾病的血液标记物及其诊断方法,更具体地,涉及年龄相关性黄斑变性,糖尿病性视网膜病,白内障的诊断方法。选自青光眼的一种或多种引起失明的眼疾,组合物,试剂盒以及使用该组合物诊断眼失明的方法。本发明的诊断致盲性眼病的方法,诊断组合物,诊断试剂盒或提供诊断所必需的信息的方法是使用患者血浆的新型免疫学诊断工具,具有优异的灵敏度,血浆使用活检。除了能够容易地分析靶标之外,通过结合蛋白质的定量值和诊断标志物的基本临床信息,证实了显示出高诊断能力,因此可以有效地用于引起失明的诊断。眼疾。

著录项

  • 公开/公告号KR20200112728A

    专利类型

  • 公开/公告日2020-10-05

    原文格式PDF

  • 申请/专利权人 (주)레티마크;

    申请/专利号KR20200034246

  • 发明设计人 박성준;

    申请日2020-03-20

  • 分类号C12Q1/6883;G01N33/68;

  • 国家 KR

  • 入库时间 2022-08-21 11:05:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号